128 related articles for article (PubMed ID: 25972517)
1. A Systematic Comparison of 18F-C-SNAT to Established Radiotracer Imaging Agents for the Detection of Tumor Response to Treatment.
Witney TH; Hoehne A; Reeves RE; Ilovich O; Namavari M; Shen B; Chin FT; Rao J; Gambhir SS
Clin Cancer Res; 2015 Sep; 21(17):3896-905. PubMed ID: 25972517
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Kinetic Analysis of the Caspase-3/7 PET Tracer 18F-C-SNAT: Quantifying the Changes in Blood Flow and Tumor Retention After Chemotherapy.
Palner M; Shen B; Jeon J; Lin J; Chin FT; Rao J
J Nucl Med; 2015 Sep; 56(9):1415-21. PubMed ID: 26045308
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis imaging probe predicts early chemotherapy response in preclinical models: A comparative study with 18F-FDG PET.
Song S; Xiong C; Lu W; Ku G; Huang G; Li C
J Nucl Med; 2013 Jan; 54(1):104-10. PubMed ID: 23283564
[TBL] [Abstract][Full Text] [Related]
4.
Elvas F; Boddaert J; Vangestel C; Pak K; Gray B; Kumar-Singh S; Staelens S; Stroobants S; Wyffels L
J Nucl Med; 2017 Apr; 58(4):665-670. PubMed ID: 27879368
[TBL] [Abstract][Full Text] [Related]
5. Early Prediction of Tumor Response to Treatment: Preclinical Validation of 99mTc-Duramycin.
Elvas F; Vangestel C; Pak K; Vermeulen P; Gray B; Stroobants S; Staelens S; Wyffels L
J Nucl Med; 2016 May; 57(5):805-11. PubMed ID: 26837335
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive positron emission tomography imaging of cell death using a novel small-molecule probe, (18)F labeled bis(zinc(II)-dipicolylamine) complex.
Wang H; Tang X; Tang G; Huang T; Liang X; Hu K; Deng H; Yi C; Shi X; Wu K
Apoptosis; 2013 Aug; 18(8):1017-27. PubMed ID: 23613106
[TBL] [Abstract][Full Text] [Related]
7. A preliminary study of imaging paclitaxel-induced tumor apoptosis with (99)Tc(m)-His10-Annexin V.
Zheng YM; Wang F; Fang W; Hua ZC; Wang ZZ; Meng QL; Yan J
Chin Med J (Engl); 2013; 126(15):2928-33. PubMed ID: 23924470
[TBL] [Abstract][Full Text] [Related]
8. Preclinical assessment of carboplatin treatment efficacy in lung cancer by 18F-ICMT-11-positron emission tomography.
Witney TH; Fortt R; Aboagye EO
PLoS One; 2014; 9(3):e91694. PubMed ID: 24618809
[TBL] [Abstract][Full Text] [Related]
9. Positron Emission Tomography Imaging of Tumor Apoptosis with a Caspase-Sensitive Nano-Aggregation Tracer [
Chen Z; Rao J
Methods Mol Biol; 2018; 1790():181-195. PubMed ID: 29858792
[TBL] [Abstract][Full Text] [Related]
10. [
Chen M; Chen Z; Castillo JB; Cui L; Zhou K; Shen B; Xie J; Chin FT; Rao J
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3386-3399. PubMed ID: 33712870
[TBL] [Abstract][Full Text] [Related]
11. Monitoring therapeutic response of human ovarian cancer to trastuzumab by SPECT imaging with (99m)Tc-peptide-Z(HER2:342).
Zhang J; Zhao X; Wang S; Wang N; Han J; Jia L; Ren X
Nucl Med Biol; 2015 Jun; 42(6):541-6. PubMed ID: 25735223
[TBL] [Abstract][Full Text] [Related]
12. Single-photon emission computed tomographic imaging of the early time course of therapy-induced cell death using technetium 99m tricarbonyl His-annexin A5 in a colorectal cancer xenograft model.
Vangestel C; Van de Wiele C; Mees G; Mertens K; Staelens S; Reutelingsperger C; Pauwels P; Van Damme N; Peeters M
Mol Imaging; 2012 Apr; 11(2):135-47. PubMed ID: 22469241
[TBL] [Abstract][Full Text] [Related]
13. Impact of animal handling on the results of 18F-FDG PET studies in mice.
Fueger BJ; Czernin J; Hildebrandt I; Tran C; Halpern BS; Stout D; Phelps ME; Weber WA
J Nucl Med; 2006 Jun; 47(6):999-1006. PubMed ID: 16741310
[TBL] [Abstract][Full Text] [Related]
14. 111In-cetuximab-F(ab')2 SPECT and 18F-FDG PET for prediction and response monitoring of combined-modality treatment of human head and neck carcinomas in a mouse model.
van Dijk LK; Boerman OC; Franssen GM; Kaanders JH; Bussink J
J Nucl Med; 2015 Feb; 56(2):287-92. PubMed ID: 25552666
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
16. Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII.
Nielsen CH; Erlandsson M; Jeppesen TE; Jensen MM; Kristensen LK; Madsen J; Petersen LC; Kjaer A
J Nucl Med; 2016 Jan; 57(1):89-95. PubMed ID: 26383146
[TBL] [Abstract][Full Text] [Related]
17. Radiopharmacological evaluation of (18)F-labeled phosphatidylserine-binding peptides for molecular imaging of apoptosis.
Wuest M; Perreault A; Kapty J; Richter S; Foerster C; Bergman C; Way J; Mercer J; Wuest F
Nucl Med Biol; 2015 Nov; 42(11):864-74. PubMed ID: 26205076
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG small-animal PET/CT differentiates trastuzumab-responsive from unresponsive human breast cancer xenografts in athymic mice.
McLarty K; Fasih A; Scollard DA; Done SJ; Vines DC; Green DE; Costantini DL; Reilly RM
J Nucl Med; 2009 Nov; 50(11):1848-56. PubMed ID: 19837760
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal PET imaging of doxorubicin-induced cell death with 18F-Annexin V.
Hu S; Kiesewetter DO; Zhu L; Guo N; Gao H; Liu G; Hida N; Lang L; Niu G; Chen X
Mol Imaging Biol; 2012 Dec; 14(6):762-70. PubMed ID: 22392643
[TBL] [Abstract][Full Text] [Related]
20. Measurement of Tumor Antioxidant Capacity and Prediction of Chemotherapy Resistance in Preclinical Models of Ovarian Cancer by Positron Emission Tomography.
Greenwood HE; McCormick PN; Gendron T; Glaser M; Pereira R; Maddocks ODK; Sander K; Zhang T; Koglin N; Lythgoe MF; Årstad E; Hochhauser D; Witney TH
Clin Cancer Res; 2019 Apr; 25(8):2471-2482. PubMed ID: 30651275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
